Drug intelligence / Profile preview

ASYNYDA-FITC

Development stage
Phase 1
Lead developer
University of Michigan
Modality
Peptides
Administration
Topical
01

Overview

ASYNYDA-FITC is an investigational diagnostic peptide-dye conjugate developed by the University of Michigan for the real-time detection of esophageal neoplasia. It consists of a seven-amino acid peptide with the sequence ASYNYDA, linked to a fluorescein isothiocyanate (FITC) fluorophore via a GGGSK linker. The peptide was identified through phage display technology to bind specifically to cell surface markers that are overexpressed during the progression from Barrett's esophagus to esophageal adenocarcinoma. During an upper gastrointestinal endoscopy, the agent is applied topically to the esophageal mucosa via a spray catheter. When viewed under a specialized fluorescence endoscope, the peptide allows clinicians to visualize dysplastic or malignant tissue that may be inconspicuous under standard white-light imaging, thereby facilitating targeted biopsies and improving the detection of early-stage lesions.

Other names
Fluorescent peptideFITC-labeled heptapeptideFluorescently labeled ASYNYDA
02

Targets

BSG (Basigin)

Beyond the preview

Go deeper on ASYNYDA-FITC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ASYNYDA-FITC.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call